According to a new study, mRNA COVID-19 vaccines pose the higher risk of possibly heart inflammation in young men more than the virus itself.
According to a pre-print study published last month by British researchers, each dose of the COVID vaccine increases the risk of myocarditis in men under the age of 40. Myocarditis is a life-threatening condition of cardiac inflammation that regulators have previously linked to the mRNA vaccines produced by Moderna and Pfizer.
The researchers studied the results of about 42 million adults in the United Kingdom aged 13 years or older who received at least one COVID shot, including around 22 million who received an mRNA jab. They did not examine for other cardiac complications connected with COVID injections, such as pericarditis and blood clots.
According to the study, the risk of heart inflammation in young men increased with each Pfizer or Moderna dose. After receiving an initial Pfizer vaccine, the risk of myocarditis doubled and then tripled again, reaching more than 7.6 times the baseline risk.
After a second dose of Moderna, the risk was 16 times greater than the norm.
The Oxford-AstraZeneca vaccine, an adenovirus vector vaccine, also increased the incidence of myocarditis in young men following the second dosage, though the increase was less than that seen with either mRNA vaccine.
Alex Berenson, a former New York Times reporter, stated that the cardiac dangers are most likely dose-related, as the Moderna shot has 100 micrograms of mRNA, compared to 30 for Pfizer.
Berenson stated that the British study provides evidence that myocarditis following mRNA immunization is potentially more harmful than other types of the illness.
The researchers detected around 550 occurrences of myocarditis within four weeks of immunization and 79 post-vaccination myocarditis deaths, 38 of which happened following a Pfizer dose. 14 percent of patients hospitalized following Pfizer vaccination died, compared to 9 percent of those who did not receive a recent mRNA vaccine. Myocarditis fatality rates were significantly greater than those for cardiac inflammation caused by COVID following any dosage of the Pfizer vaccination.
Additionally, young males had a greater rate of hospitalization for myocarditis following a second AstraZeneca or Pfizer shot or dose of Moderna, compared to myocarditis caused by COVID-19.
Among the study’s other results is that roughly half of the 5 million persons who got the virus did so following at least one vaccination. Almost a third, or 1.6 million people, tested positive despite having received two doses of the vaccine.
The new study comes as hundreds of schools and universities require students to have a booster shot prior to returning to campus, despite the risk of myocarditis for male students and the exceedingly low risk of COVID-19 infection for younger age groups. Notre Dame, Georgetown, and MIT are among the universities, as is the whole of the Ivy League.
Stanford University medical professor Dr. John Ionnidis has estimated the survival rate of coronavirus for people between age 20 and 29 at 99.986 percent.